Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Latella

Showing results (61-70 of 147) with videos related to

Pageof 15
Sort By:
International Journal of Molecular Sciences|August 23, 2019
Can Nrf2 Modulate the Development of Intestinal Fibrosis and Cancer in Inflammatory Bowel Disease?Simona Pompili, Roberta Sferra, Eugenio Gaudio, et al.
International Journal of Medical Sciences|January 13, 2021
Sleep disorders related to nutrition and digestive diseases: a neglected clinical conditionFilippo Vernia, Mirko Di Ruscio, Antonio Ciccone, et al.
International Journal of Colorectal Disease|November 30, 2002
Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colonGiovanni Latella, Maria Teresa Pimpo, Sandra Sottili, et al.
Vaccines|May 25, 2024
Vaccine Acceptance in Patients with Inflammatory Bowel Disease: Lessons Learned from the COVID-19 PandemicGiada Mastrangeli, Filippo Vernia, Stefano Necozione, et al.
Medicina (Kaunas, Lithuania)|October 28, 2023
COVID-19 and Gastrointestinal Tract: From Pathophysiology to Clinical ManifestationsFilippo Vernia, Hassan Ashktorab, Nicola Cesaro, et al.
European Journal of Histochemistry : EJH|August 2, 2018
Interaction between sphingosine kinase/sphingosine 1 phosphate and transforming growth factor-β/Smads pathways in experimental intestinal fibrosis. An in vivo immunohistochemical studyRoberta Sferra, Simona Pompili, Luca Ventura, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2009
Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in miceGiovanni Latella, Antonella Vetuschi, Roberta Sferra, et al.
Digestion|June 6, 2015
Non-Celiac Gluten Sensitivity among Patients Perceiving Gluten-Related SymptomsAnnalisa Capannolo, Angelo Viscido, Mohamed Ali Barkad, et al.
BMC Gastroenterology|March 4, 2022
Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitisAngelo Viscido, Marco Valvano, Gianpiero Stefanelli, et al.
Journal of Clinical Medicine|May 13, 2023
Prophylactic Treatment with Vedolizumab in the Prevention of Postoperative Recurrence (POR) in High-Risk Crohn's PatientsGiuseppe Frieri, Marco Valvano, Sara Frassino, et al.
Pageof 15

Showing results (61-70 of 147) with videos related to

Sort By:
Pageof 15
International Journal of Molecular Sciences|August 23, 2019
Can Nrf2 Modulate the Development of Intestinal Fibrosis and Cancer in Inflammatory Bowel Disease?Simona Pompili, Roberta Sferra, Eugenio Gaudio, et al.
International Journal of Medical Sciences|January 13, 2021
Sleep disorders related to nutrition and digestive diseases: a neglected clinical conditionFilippo Vernia, Mirko Di Ruscio, Antonio Ciccone, et al.
International Journal of Colorectal Disease|November 30, 2002
Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colonGiovanni Latella, Maria Teresa Pimpo, Sandra Sottili, et al.
Vaccines|May 25, 2024
Vaccine Acceptance in Patients with Inflammatory Bowel Disease: Lessons Learned from the COVID-19 PandemicGiada Mastrangeli, Filippo Vernia, Stefano Necozione, et al.
Medicina (Kaunas, Lithuania)|October 28, 2023
COVID-19 and Gastrointestinal Tract: From Pathophysiology to Clinical ManifestationsFilippo Vernia, Hassan Ashktorab, Nicola Cesaro, et al.
European Journal of Histochemistry : EJH|August 2, 2018
Interaction between sphingosine kinase/sphingosine 1 phosphate and transforming growth factor-β/Smads pathways in experimental intestinal fibrosis. An in vivo immunohistochemical studyRoberta Sferra, Simona Pompili, Luca Ventura, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2009
Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in miceGiovanni Latella, Antonella Vetuschi, Roberta Sferra, et al.
Digestion|June 6, 2015
Non-Celiac Gluten Sensitivity among Patients Perceiving Gluten-Related SymptomsAnnalisa Capannolo, Angelo Viscido, Mohamed Ali Barkad, et al.
BMC Gastroenterology|March 4, 2022
Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitisAngelo Viscido, Marco Valvano, Gianpiero Stefanelli, et al.
Journal of Clinical Medicine|May 13, 2023
Prophylactic Treatment with Vedolizumab in the Prevention of Postoperative Recurrence (POR) in High-Risk Crohn's PatientsGiuseppe Frieri, Marco Valvano, Sara Frassino, et al.
Pageof 15